###begin article-title 0
###xml 43 48 43 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MATN3</italic>
Multiple epiphyseal dysplasia mutations in MATN3 cause misfolding of the A-domain and prevent secretion of mutant matrilin-3
###end article-title 0
###begin p 1
###xml 294 299 294 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MATN3</italic>
###xml 565 570 565 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MATN3</italic>
###xml 1211 1216 1211 1216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MATN3</italic>
###xml 1637 1642 1637 1642 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MATN3</italic>
###xml 1196 1203 <span type="species:ncbi:9606">patient</span>
Multiple epiphyseal dysplasia (MED) is a relatively common skeletal dysplasia that can present in childhood with a variable phenotype of short stature and pain and stiffness in the large joints, and often progresses to early-onset osteoarthritis in adulthood. Mutations in the matrilin-3 gene (MATN3) have recently been shown to underlie some forms of autosomal dominant MED. To date all MED mutations in matrilin-3 cluster in the single A-domain, suggesting that they may disrupt the structure and/or function of this important domain. To determine the effects of MATN3 mutations on the structure and function of matrilin-3 we expressed both normal and mutant matrilin-3 in mammalian cells. Wild-type (wt) matrilin-3 was efficiently secreted into conditioned medium, whereas mutant matrilin-3 was retained and accumulated within the cell. Furthermore, when the mutant A-domains were examined individually, they existed primarily in an unfolded conformation. Co-immunoprecipitation experiments demonstrated that the mutant A-domains were specifically associated with ERp72, a chaperone protein known to be involved in mediating disulfide bond formation. Light microscopy of cartilage from an MED patient with a MATN3 mutation showed the presence of intracellular material within the chondrocytes, whilst the overall matrix appeared normal. On electron micrographs, the inclusions noted at the light microscopy level appeared to be dilated cisternae of rough endoplasmic reticulum and immunohistochemical analysis confirmed that the retained protein was matrilin-3. In summary, the data presented in this paper suggest that MED caused by MATN3 mutations is the result of an intracellular retention of the mutant protein.
###end p 1
###begin title 2
INTRODUCTION
###end title 2
###begin p 3
###xml 123 149 123 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b17">Hohenester and Engel, 2002</xref>
###xml 336 361 336 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b39">Whittaker and Hynes, 2002</xref>
###xml 784 807 784 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b13">Fitzgerald et al., 2002</xref>
###xml 809 829 809 829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b38">Wagener et al., 2005</xref>
###xml 831 856 831 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b39">Whittaker and Hynes, 2002</xref>
###xml 985 1011 978 1004 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9">Dickeson and Santoro, 1998</xref>
Extracellular matrix (ECM) proteins typically comprise several different structural domains that often occur in multiples [Hohenester and Engel, 2002]. In some instances the same domain can be found in many different proteins, each of which has a distinct function. One such protein domain is the von Willebrand factor A-domain (vWFA) [Whittaker and Hynes, 2002]. This domain was originally identified in von Willebrand factor, a soluble plasma protein that plays a role in blood clotting by mediating platelet adhesion to the collagen fibrils of damaged blood vessels. Von Willebrand factor A-domains (A-domains) are also found in collagen types VI, type VII, type XII, type XIV, type XVII, type XX, type XXI, and other ECM proteins such as matrilins 1-4, cochlin, vitrin, and WARP [Fitzgerald et al., 2002; Wagener et al., 2005; Whittaker and Hynes, 2002]. A homologue of the A-domain is the integrin inserted-domain or I-domain, which is found in many alpha and all beta integrins [Dickeson and Santoro, 1998].
###end p 3
###begin p 4
###xml 271 296 261 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b39">Whittaker and Hynes, 2002</xref>
The A-domain consists of approximately 200 amino acids arranged in a Rossman or dinucleotide-binding fold, with five parallel beta-strands and one antiparallel beta-strand at the center of the domain surrounded by seven alpha-helices on the external faces of the domain [Whittaker and Hynes, 2002]. Many A-domains can coordinate a metal ion using noncontiguous residues at the top of the domain called the metal ion-dependent adhesion site (MIDAS) motif.
###end p 4
###begin p 5
###xml 258 274 254 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b29">Pan et al., 1998</xref>
###xml 377 396 373 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b32">Sasaki et al., 2000</xref>
###xml 670 688 662 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b30">Ribba et al., 2001</xref>
###xml 12 17 <span type="species:ncbi:9606">human</span>
###xml 212 220 <span type="species:ncbi:9606">patients</span>
A number of human diseases are caused by the mutation of residues within the A-domains of various proteins. A missense mutation (p.Gly1679Glu) in the A-domain of the alpha3 chain of type VI collagen was found in patients with Bethlem myopathy (MIM# 158810) [Pan et al., 1998] and has been shown to result in reduced secretion and increased degradation of mutant a3(VI) chains [Sasaki et al., 2000]. Furthermore, a missense mutation in the alpha3 domain of von Willebrand factor results in reduced collagen binding by the mutant protein and an inherited hemorrhagic syndrome, while the mutant monomers were still able to assemble into multimers and bind glycoprotein 1b [Ribba et al., 2001]. Overall, these data suggest that the type and location of a particular mutation within the A-domain determine the specific disease mechanism and ultimately the phenotypic consequence.
###end p 5
###begin p 6
###xml 195 220 195 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4">Briggs and Chapman, 2002;</xref>
###xml 220 241 220 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b35">Unger and Hecht, 2001</xref>
###xml 388 407 388 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5">Briggs et al., 1995</xref>
###xml 454 468 450 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL9A1, COL9A2</italic>
###xml 474 480 470 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL9A3</italic>
###xml 530 560 526 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8">Czarny-Ratajczak et al., 2001;</xref>
###xml 560 581 556 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b27">Muragaki et al., 1996</xref>
###xml 583 605 579 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b28">Paassilta et al., 1999</xref>
###xml 623 628 619 624 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MATN3</italic>
###xml 644 664 640 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">Chapman et al., 2001</xref>
Multiple epiphyseal dysplasia (MED) is a skeletal dysplasia of varying severity and is characterized by stiffness and pain in the large joints, which often results in early-onset osteoarthritis [Briggs and Chapman, 2002;Unger and Hecht, 2001]. Several genes have been implicated in autosomal dominant MED, including those encoding cartilage oligomeric matrix protein (COMP; MIM# 132400) [Briggs et al., 1995], all three alpha-chains of type IX collagen (COL9A1, COL9A2, and COL9A3; MIM# 120210, 600204, and 600969, respectively) [Czarny-Ratajczak et al., 2001;Muragaki et al., 1996; Paassilta et al., 1999] and matrilin-3 (MATN3; MIM# 607078) [Chapman et al., 2001].
###end p 6
###begin p 7
###xml 76 96 76 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b37">Wagener et al., 1997</xref>
###xml 334 351 334 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b40">Wu and Eyre, 1998</xref>
###xml 353 371 353 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b19">Klatt et al., 2000</xref>
###xml 488 512 488 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4">Briggs and Chapman, 2002</xref>
###xml 514 531 514 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b23">Mann et al., 2004</xref>
Matrilin-3 is a modular protein found specifically in the ECM of cartilage [Wagener et al., 1997]. It comprises a single A-domain, four EGF repeats, and a coiled-coil domain that facilitates oligomerization. It is the third member of the matrilin family of proteins, and forms either homotetramers or heterotetramers with matrilin-1 [Wu and Eyre, 1998; Klatt et al., 2000]. Matrilin-3/1 isolated from cartilage has been shown to bind with high affinity to both COMP and type IX collagen [Briggs and Chapman, 2002; Mann et al., 2004].
###end p 7
###begin p 8
###xml 30 35 30 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MATN3</italic>
###xml 91 114 91 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b2">Belluoccio et al., 1998</xref>
###xml 147 152 147 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MATN3</italic>
###xml 220 240 220 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">Chapman et al., 2001</xref>
###xml 299 319 299 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18">Jackson et al., 2004</xref>
###xml 397 417 397 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18">Jackson et al., 2004</xref>
###xml 655 660 655 660 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MATN3</italic>
###xml 810 833 810 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b33">Stefansson et al., 2003</xref>
###xml 992 1016 992 1016 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3">Borochowitz et al., 2004</xref>
###xml 514 522 <span type="species:ncbi:9606">patients</span>
The gene encoding matrilin-3 (MATN3) is located on chromosome 2 and comprises eight exons [Belluoccio et al., 1998]. Several missense mutations in MATN3 have been associated with MED, including p.Arg121Trp, p.Val194Asp [Chapman et al., 2001], p.Thr120Met, p.Glu134Lys, p.Ile192Asn, and p.Ala219Asp [Jackson et al., 2004]. In addition, we also identified a nonsynonymous polymorphism, p.Glu252Lys [Jackson et al., 2004], which apparently does not cause MED but may play a role in modifying disease severity in some patients. All of these missense mutations and the polymorphism are found in the single A-domain of matrilin-3, which is encoded by exon 2 of MATN3. Interestingly, a form of hand osteoarthritis (MIM# 607850) has been linked to a p.Thr303Met mutation located in the first EGF repeat of matrilin-3 [Stefansson et al., 2003], while a recessive form of spondyloepimetaphyseal dysplasia (MIM# 608728) results from homozygosity for a mutation (p.Cys304Ser) at the neighboring residue [Borochowitz et al., 2004].
###end p 8
###begin p 9
To understand the effect of MED-causing mutations on the structure and function of matrilin-3 and thereby gain insight into the disease mechanisms of this form of MED, we expressed both normal and mutant full-length matrilin-3 proteins and single A-domains in mammalian cells. This approach allowed us to investigate the effects of mutations on the folding and trafficking of matrilin-3 and propose a potential disease mechanism for this form of MED.
###end p 9
###begin title 10
MATERIALS AND METHODS
###end title 10
###begin title 11
Cloning of Normal and Mutant Matrilin-3 A-Domains
###end title 11
###begin p 12
###xml 31 36 31 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MATN3</italic>
###xml 115 128 115 128 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ggcccagccggcc</underline>
###xml 154 157 154 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sfi</italic>
###xml 207 215 207 215 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gcggccgc</underline>
###xml 241 244 241 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Not</italic>
###xml 338 343 338 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MATN3</italic>
###xml 633 636 631 634 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Taq</italic>
###xml 701 702 693 694 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 703 704 695 696 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 706 707 698 699 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 720 721 712 713 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1423 1426 1382 1385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sfi</italic>
###xml 1433 1436 1392 1395 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Not</italic>
###xml 324 332 <span type="species:ncbi:9606">patients</span>
PCR amplification of exon 2 of MATN3, which encoded the entire A-domain, was performed using primers MATN3ex2F (5'-ggcccagccggcctgcaagagcagacccttggac-3', Sfi I restriction site underlined) and MATN3ex2R (5'-gcggccgcacagaaggtttcctggaatct-3', Not I restriction site underlined) using a standard protocol. Genomic DNA from MED patients with MATN3 mutations (p.Arg121Trp, p.Val194Asp, p.Thr120Met, p.Glu134Lys, p.Ile192Asn, and p.Ala219Asp) and the nonsynonymous polymorphism (p.Glu252Lys) was used as the template in the PCR. In brief, PCR amplifications were performed in 25 mul reactions containing 0.5 muM of each primer, 0.625 U of Taq DNA polymerase, 67 mM Tris-HCl (pH 8.0 at 25degreesC), 16 mM (NH4)2SO4, 3.7 mM MgCl2, 0.085 mg/ml BSA, 6.7 muM EDTA, 0.75 mM of each dNTP, and 50-100 ng of genomic DNA. PCR cycling consisted of initial denaturation at 95degreesC for 3 min followed by 35 cycles of 95degreesC for 1 min, 62degreesC for 1 min, and 72degreesC for 1 min and a final extension at 72degreesC for 5 min. PCR amplified DNA fragments were purified using the QIAquick(R) PCR purification kit (Qiagen Ltd., Crawley, West Sussex; ) and individual alleles were cloned using the TA cloning kit (Invitrogen Ltd., Paisley, UK; ) following the manufacturer's instructions. Clones containing only the nucleotide change of interest, as identified by bi-directional DNA sequencing, underwent double restriction digest with Sfi I and Not I and were sub-cloned into pSecTag2A (Invitrogen).
###end p 12
###begin title 13
Cloning of Normal and Mutant Full-Length Matrilin-3
###end title 13
###begin p 14
###xml 82 84 82 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">st</italic>
###xml 252 258 252 258 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tctaga</underline>
###xml 272 275 272 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xba</italic>
###xml 319 325 319 325 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">aagctt</underline>
###xml 352 356 352 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hind</italic>
###xml 422 424 422 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fu</italic>
###xml 567 570 565 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xba</italic>
###xml 577 581 575 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hind</italic>
###xml 631 634 629 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xba</italic>
###xml 637 641 635 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hind</italic>
###xml 833 836 831 834 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Eco</italic>
###xml 840 843 838 841 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xba</italic>
###xml 873 876 871 874 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Eco</italic>
###xml 880 883 878 881 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xba</italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 161 164 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 663 666 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
Human full-length matrilin-3 cDNA (a kind gift from D. Krakow) was digested with Pst I and subcloned into the pCMVTAG4 (Stratagene, La Jolla, CA; ) vector (FLM3-CMV). PCR amplification to remove the stop codon was then performed using M3XbaF (5'-ctttcctctagattccaggaa-3', Xba I restriction site underlined) and M3R (5'-aagcttacgatgtatttgtccat attc-3', Hind III restriction site underlined) using a standard protocol with Pfu DNA polymerase. The PCR amplified DNA fragment was purified using the QIAquick(R) PCR purification kit (Qiagen) and then double digested with Xba I and Hind III. The digested fragment replaced the original Xba I/Hind III fragment in FLM3-CMV to create WT-FLM3 (wt full-length matrilin-3) with no stop codon and in-frame with the FLAG tag. p.Val194Asp and p.Glu252Lys mutations were introduced by replacing a Eco NI/Xba I fragment from WT-FLM3 with Eco NI/Xba I fragments from the respective mutant A-domains (see previous) using standard protocols. All clones were sequenced to confirm that they contained only the desired mutation.
###end p 14
###begin title 15
Cell Culture and Transfection
###end title 15
###begin p 16
###xml 77 78 77 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</italic>
###xml 230 231 223 224 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
CHO-B2 cells were cultured in Ham's F12 media supplemented with 10% FBS, 2mM L-glutamine, 100 U/ml penicillin, and 100 mug/ml streptomycin (Biowhittaker; ). The cells were incubated at 37degreesC in humidified air containing 5% CO2.
###end p 16
###begin p 17
###xml 168 169 168 169 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 683 684 669 670 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
The cells were transfected using Lipofectin (Invitrogen) according to the manufacturer's instructions. Briefly, when the cells were 50-70% confluent monolayers in 75 cm2 flasks they were incubated with 2 mug of construct DNA and Lipofectin in Opti-MEM serum-free media (Invitrogen) for 24 hr. To obtain stable cell lines the cells were transferred to media containing 250 mug/ml Zeocin (Invitrogen) for selection. This media was changed every 2-3 days until distinct foci of individual clones resistant to Zeocin could be seen (after approximately2 weeks). Individual clones were removed by incubation with trypsin, expanded in 6-well plates and when confluent transferred into 25 cm2 flasks. Conditioned media and cell lysates were tested for expression of the A-domain and individual cell lines that expressed the A-domain to the highest extent were then used in subsequent experiments.
###end p 17
###begin title 18
SDS-PAGE and Western Blot Analysis
###end title 18
###begin p 19
Cells were lysed by incubation in 500 mul RIPA lysis buffer (10 mM Tris, pH 7.4, 150 mM NaCl, 1% sodium deoxycholate, 0.1% SDS) on ice for 15 min. The cell monolayer was removed, centrifuged at 13,600 x g for 5 min and the supernatant was removed for analysis. Conditioned media and cell lysates were separated by SDS-PAGE on 4-12% Tris-Bis gels (Invitrogen). Proteins were transferred to nitrocellulose membranes and the recombinant A-domain was detected using an anti-c-myc monoclonal antibody, clone 9E10 (Roche Diagnostics Ltd. Lewes, East Sussex, UK; ) with antimouse HRP conjugate (Sigma-Aldrich Company Ltd., Gillingham, Dorset, UK; ) as a secondary antibody. Protein bands were visualised with SuperSignal(R) West Dura extended duration substrate (Perbio; ).
###end p 19
###begin title 20
Co-immunoprecipitation With Chaperone Antibodies
###end title 20
###begin p 21
###xml 84 85 84 85 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
Co-immunoprecipitation was carried out on cell lysates produced as above from 5 x 105 cells transfected with the different A-domain constructs. Proteins were precipitated using antibodies against chaperones found in the rough endoplasmic reticulum (rER): PDI, ERp72 (Stressgen, San Diego, CA; /), Grp78, Grp94 (Santa Cruz Biotechnology, Santa Cruz, CA; ). Prior to immunoprecipitation, the cells were cross linked with dithiobis[succinimidyl propionate] (DSP) to stabilize protein complexes. Aliquots of cells were washed twice in PBS then resuspended in 250 mul PBS. DSP was added to 1 mM from a fresh stock made up in dry DMSO and incubated for 30 min at room temperature. To stop the cross-linking reaction, 10 mul of 1 M Tris-HCl, pH 7.4 was added and cells were incubated for a further 15 min. Finally, cells were washed twice in PBS and lysed with RIPA lysis buffer as described above ready for immunoprecipitation.
###end p 21
###begin p 22
###xml 191 197 <span type="species:ncbi:9986">rabbit</span>
###xml 203 207 <span type="species:ncbi:9925">goat</span>
Lysates were diluted 10-fold with immunoprecipitation buffer (50mM Tris-HCl, pH 7.4, 1% Triton X-100, 150 mM NaCl, 2 mM EDTA). First, cell lysates were precleared by incubation with 0.25 mug rabbit IgG (goat IgG with anti-Grp78 and -Grp94) and 20 mul Protein A-agarose (Protein G PLUS-agarose with anti-Grp78 and -Grp94) (Santa Cruz Biotechnology) under rotation for 1 hr at 4degreesC. The mixture was centrifuged at 3,000 x g for 5 min to remove the beads and nonspecifically bound proteins. The appropriate chaperone antibody was added to the supernatant and incubated under rotation for 1 hr at 4degreesC. Then 20 mul of Protein A-agarose was added and the tubes were rotated at 4degreesC overnight. After overnight incubation, the tubes were centrifuged at 3,000 x g for 3 min and the supernatant was discarded. The pellet was washed and centrifuged three times in immunoprecipitation buffer. The final pellet was resuspended in 1 x SDS-PAGE loading buffer containing 100 mM dithiothreitol (DTT), heated at 100degreesC for 5 min and centrifuged at 6,000 x g for 30 sec. The supernatants were analyzed by Western blotting as described previously.
###end p 22
###begin title 23
Immunohistochemistry
###end title 23
###begin p 24
###xml 29 36 <span type="species:ncbi:9606">patient</span>
###xml 236 242 <span type="species:ncbi:9986">Rabbit</span>
An iliac crest biopsy from a patient with the p.Arg121Trp MED-causing mutation was stained using an anti-matrilin-3 antibody. Frozen sections (5-10 mum thick) were cut from the biopsy and mounted on superfrost slides. A Vectastain ABC (Rabbit IgG) kit (Vector Laboratories Ltd., Peterborough, UK; ) was used according to manufacturer's instructions. Antibody staining was detected with a DAB peroxidase substrate kit (Vector Laboratories Ltd.) and counterstained with hemotoxylin.
###end p 24
###begin title 25
RESULTS
###end title 25
###begin title 26
MED Mutations Cluster in the A-Domain of Matrilin-3
###end title 26
###begin p 27
###xml 212 219 212 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
###xml 595 600 574 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MATN3</italic>
###xml 694 699 673 678 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MATN3</italic>
###xml 579 587 <span type="species:ncbi:9606">patients</span>
Missense mutations in the gene encoding matrilin-3 cause an autosomal dominant form of MED and in total eleven different mutations have now been identified in 26 unrelated families with various forms of MED (see Table 1). All but one of these mutations affect residues comprising the beta-strands of the A-domain; indeed, disease-causing mutations have now been identified in four of the six beta-strands (betaB, betaC, betaD, and betaE) that comprise the single beta-sheet. The most common mutation is p.Arg121Trp, which has been identified in approximately onethird of all MED patients with a MATN3 mutation (9/26). Sufficient studies have now been performed to suggest that MED mutations in MATN3 are predominantly located in exon 2, which encodes the single A-domain.
###end p 27
###begin p 28
###xml 24 29 24 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MATN3</italic>
###xml 53 54 53 54 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="tf1-1">*</xref>
Mutations Identified in MATN3 in 26 Families with MED*
###end p 28
###begin p 29
###xml 271 276 271 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MATN3</italic>
Matrilin-3 cDNA accession number in GenBank is NM_002381.3 and nucleotide numbering is from the start of translation (i.e., +1 corresponds to the A of the ATG translation initiation codon in the reference sequence). Nucleotide mutations are based on the cDNA sequence of MATN3 and are preceded with a "c." symbol before the number.
###end p 29
###begin p 30
A non-disease-causing polymorphism identified in unaffected family members and unrelated controls.
###end p 30
###begin title 31
Expression of Normal and Mutant Matrilin-3 Proteins
###end title 31
###begin p 32
###xml 450 457 438 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig01">Fig. 1A</xref>
###xml 620 627 608 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig01">Fig. 1B</xref>
To determine the effect of MED mutations on the secretion of matrilin-3 we cloned and expressed in mammalian cells full-length wt matrilin-3 and matrilin-3 harboring a MED mutation (p.Val194Asp) and non-synonymous polymorphism (p.Glu252Lys). SDS-PAGE and Western blot analysis of proteins from the cell media showed the presence of wt and p.Glu252Lys proteins at the expected molecular weight of approximately51 kDa, but not the p.Val194Asp protein (Fig. 1A). In contrast SDS-PAGE and Western blot analysis of proteins isolated from the cell lysate showed the presence of matrilin-3 containing the p.Val194Asp mutation (Fig. 1B), but not the wt and p.Glu252Lys proteins (other than at normal background levels expected for a cell expressing high levels of a recombinant protein).
###end p 32
###begin p 33
###xml 136 137 136 137 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 142 143 142 143 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 166 167 166 167 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
SDS-PAGE and Western blot analysis of conditioned media and cell lysates from CHO cells stably transfected with full-length matrilin-3 (A and B) and single A-domain (C) constructs. Gels were run under reducing conditions, and molecular weights are shown in kDa. A and B: Media and cell lysate samples from cells expressing full-length wt, a MED mutation (pVal194Asp), and the polymorphism (pGlu252Lys) are shown. Proteins were detected with an anti-FLAG antibody, and the full-length protein is indicated with an arrowhead.C:Untransfected cells (C) and cells transfected with normal (wt) and polymorphic (pGlu252Lys) A-domain are shown.The A-domain missense mutations shown are pArg121Trp, p.Val194Asp, p.Ile192Asn, pGlu134Lys, p.Ala219Asp, and p.Thr120Met. Proteins were detected with an anti-c-myc antibody, and the A-domain is indicated with an arrowhead.
###end p 33
###begin p 34
These data therefore suggested that the p.Val194Asp mutation prevented the proper trafficking and secretion of matrilin-3, whereas as the p.Glu252Lys polymorphism did not.
###end p 34
###begin title 35
MED Mutations Disrupt the Folding of the Matrilin-3 A-Domain
###end title 35
###begin p 36
###xml 181 188 178 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
The apparent clustering of the majority of MED mutations in the beta-sheet led us to hypothesize that these substitutions were disrupting the folding of the A-domain of matrilin-3 (Table 1). Therefore, to determine the precise effect of these disease-causing mutations we expressed both normal and mutant A-domain proteins. We chose to express a number of MED mutations (p.Arg121Trp, p.Val194Asp, p.Thr120Met, p.Glu134Lys, p.Ile192Asn and p.Ala219Asp) in addition to the non-synonymous polymorphism (p.Glu252Lys).
###end p 36
###begin p 37
###xml 185 192 185 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig01">Fig. 1C</xref>
###xml 292 293 292 293 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
Following SDS-PAGE and Western blot analysis of conditioned media from cell lines stably transfected with the wt A-domain construct a protein band was detected at approximately 25 kDa (Fig. 1C). This agrees with the predicted molecular weight of the A-domain (24.2 kDa including c-myc and His6 tags) and no multimers were observed in samples analyzed without DTT (data not shown).
###end p 37
###begin p 38
###xml 284 291 284 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig01">Fig. 1C</xref>
###xml 622 629 622 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig01">Fig. 1C</xref>
SDS-PAGE and Western blot analysis of conditioned media and cell lysates from clones transfected with constructs containing the p.Arg121Trp, p.Val194Asp, p.Thr120Met, p.Glu134Lys, p.Ile192Asn and p.Ala219Asp mutations revealed that conditioned media contained no detectable A-domain (Fig. 1C). Instead the recombinant A-domain was detected in the cell lysates, suggesting that the mutant A-domains were not secreted but retained within the cell. In contrast, in those cells transfected with an expression vector containing the non-synonymous polymorphism (p.Glu252Lys), A-domain protein was detected in conditioned media (Fig. 1C), suggesting that the A-domain was secreted normally when it contained this non-disease-causing polymorphism. These data were therefore in agreement with those obtained for full-length matrilin-3 constructs.
###end p 38
###begin title 39
Retained Mutant A-Domains Are Primarily Unfolded
###end title 39
###begin p 40
###xml 233 240 233 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig02">Fig. 2A</xref>
###xml 659 666 659 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig02">Fig. 2A</xref>
###xml 894 901 894 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig02">Fig. 2B</xref>
SDS-PAGE and Western blot analysis of the wt A-domain showed that it migrated faster under non-reducing conditions, suggesting that the A-domain is smaller and more compact when the disulfide bond is intact (compare lanes 2 and 3 in Fig. 2A). This quantifiable characteristic of the recombinant A-domain therefore allowed us to study the disulfide bonded ("folded") state of both the normal and mutant A-domains in greater detail. In the conditioned media, all of the wt A-domain, and also A-domain containing the non-synonymous polymorphism (p.Glu252Lys) ran as a faster migrating, disulfide bonded protein under non-reducing conditions (Lanes marked "-" in Fig. 2A). However, SDS-PAGE and Western blot analysis of lysates from cells transfected with wt or p.Glu252Lys A-domain revealed that non-reduced samples contained a mixture of both forms of A-domain in approximately equal quantities (Fig. 2B; lanes 2 and 3), which is characteristic of a cell expressing high levels of recombinant protein that is actively being folded and secreted.
###end p 40
###begin p 41
###xml 56 57 56 57 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 77 78 77 78 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
SDS-PAGE and Western blot analysis of conditionedmedia (A) and cell lysates (B) from CHO cells stably transfected with A-domain constructs under reducing (+) and non-reducing (-) conditions. Samples from cells expressing a normal A-domain construct (wt), a polymorphic construct (p.Glu252Lys), and constructs with the p.Val194Asp, p.Ala219Asp, and p.Arg121Trp mutations are shown. Samples from untransfected cells were used as a control (C).The recombinant protein was detected using an anti-c-myc antibody, andmolecular weights are shown in kDa.
###end p 41
###begin p 42
###xml 265 272 265 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig02">Fig. 2B</xref>
On the other hand, when cell lysates from cells transfected with the mutant A-domains (p.Val194Asp, p.Ala219Asp, p.Arg121Trp) were analyzed by SDS-PAGE and Western blotting, the distribution of folded and unfolded A-domain was different to that of the wt A-domain (Fig. 2B; lanes 4-6). Mutant A-domains analyzed under non-reducing conditions appeared principally as the non-disulfide bonded and extended form (approximately90%), with only a small proportion of the sample in the more compact form with the disulfide bond intact (approximately10%), suggesting that the folding is either delayed or incomplete due to these mutations. In addition, disulfide bonded dimers of around 50 kDa and small quantities of trimers of around 75 kDa could also be observed (data not shown). These aggregates were not observed with either the wt or p.Glu252Lys A-domain proteins.
###end p 42
###begin title 43
Retained Mutant A-Domains Associate With the Chaperone ERp72
###end title 43
###begin p 44
Since mutant A-domain was retained within the cell lysate and appeared incorrectly folded (i.e., probably without an intrachain disulfide bond); we examined the role that specific chaperone proteins may play in this process. Co-immunoprecipitation with various anti-chaperone protein antibodies was therefore used to identify putative interactions with the wt, polymorphic (p.Glu252Lys) and mutant A-domains (p.Val194Asp, p.Arg121Trp and p.Ala219Asp).
###end p 44
###begin p 45
###xml 425 432 425 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig03">Fig. 3A</xref>
###xml 616 623 616 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig03">Fig. 3B</xref>
SDS-PAGE and Western blot analysis of total cell extracts revealed equivalent amounts of ERp72, PDI, Grp78 and Grp94 in all five cell lines (data not shown). However co-immunoprecipitation of the cell lysates with the anti-ERp72 antibody followed by SDS-PAGE and Western blot analysis of the immunoprecipitates showed that only the mutant A-domains co-precipitated with ERp72, whereas the wt or p.Glu252Lys A-domain did not (Fig. 3A). Immunoprecipitation experiments in the absence of the anti-ERp72 antibody demonstrated that the signal was not caused by non-specific binding of the A-domains to the agarose beads (Fig. 3B). Coimmunoprecipitation with antibodies to other chaperone proteins did not identify any specific interactions with mutant A-domains (data not shown).
###end p 45
###begin p 46
###xml 0 2 0 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A:</bold>
###xml 363 365 363 365 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B:</bold>
A: ERp72 was immunoprecipitated from the cell lysates of recombinant cells, and the immunoprecipitates were analyzed byWestern blot.The c-myc antibody detected recombinant A-domain in the R121W and A219D immunoprecipitates and to a lesser extent in theV194D immunoprecipitate. No band was detectable in the normal (wt), polymorphic (E252K), or control (C) lanes. B: Immunoprecipitation in the absence of anti-ERp72 antibody was performed as a control for nonspecific binding to theProteinA-agarose beads.Untransfected CHO cells were used as the control (C).
###end p 46
###begin title 47
Mutant Matrilin-3 is Retained in the Rough Endoplasmic Reticulum InVivo
###end title 47
###begin p 48
###xml 257 264 257 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig04">Fig. 4A</xref>
###xml 421 440 421 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25">Morris et al., 2002</xref>
###xml 588 595 588 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig04">Fig. 4B</xref>
###xml 732 739 732 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig04">Fig. 4C</xref>
###xml 823 830 823 830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig04">Fig. 4D</xref>
###xml 50 57 <span type="species:ncbi:9606">patient</span>
Hyaline cartilage from an iliac crest biopsy of a patient with the p.Arg121Trp mutation was analyzed using light and electron microscopy. In light micrographs the cartilage as a whole appeared normal following standard hematoxylin and eosin (H&E) staining (Fig. 4A). The cells have a normal chondrocyte morphology (i.e. rounded) and are distributed evenly throughout the extracellular matrix, which stains homogeneously [Morris et al., 2002]. However, at higher magnification the cytoplasm of the chondrocytes showed putative inclusions, which appeared to contain proteinaceous material (Fig. 4B). Immunohistochemical staining of this cartilage using an anti-matrilin-3 antibody confirmed that the retained material was matrilin-3 (Fig. 4C), which did not appear in the cytoplasm of chondrocytes of an age matched control (Fig. 4D). The resolution of these images was not sufficient to pinpoint the intracellular location of matrilin-3.
###end p 48
###begin p 49
###xml 128 130 128 130 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A:</bold>
###xml 212 214 212 214 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B:</bold>
###xml 425 427 425 427 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C:</bold>
###xml 700 701 700 701 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 747 748 747 748 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 753 755 753 755 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F:</bold>
###xml 970 971 970 971 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</bold>
###xml 1072 1076 1072 1076 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMP</italic>
###xml 1183 1184 1183 1184 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</bold>
###xml 89 96 <span type="species:ncbi:9606">patient</span>
###xml 507 514 <span type="species:ncbi:9606">patient</span>
###xml 784 792 <span type="species:ncbi:9606">patients</span>
###xml 1057 1064 <span type="species:ncbi:9606">patient</span>
Light and electron micrographs of cartilage from the iliac crest biopsy of a 14-year-old patient with the p.Arg121Trp mutation. A: H&E staining of hyaline cartilage showing a normal matrix at x 10 magnification. B: Magnification (x 100) of the same section of cartilage showing a chondrocyte with apparent staining of the cytoplasm suggesting the presence of protein material, which is distinct from the nucleus (dark blue). C: Immunohistochemistry of the cartilage showing that the protein retained in the patient's chondrocyte stains with an antibody to matrilin-3 (brown), whereas there appears to be no intracellular staining for matrilin- 3 in the chondrocyte of an aged matched control sample (D) (the cell nucleus is stained blue by DAPI). E and F: Electron micrographs of the patients chondrocytes showing that the rough endoplasmic reticulum cisternae are swollen with accumulated protein that has a granular appearance, when compared to a control chondrocyte (G). For comparison an electron micrograph of a chondrocyte from a pseudoachondroplasia patient with a COMP mutation (p.Gly465Ser) is also shown and in this case the enlarged rER completely occupies the cytoplasm (H). rER: rough endoplasmic reticulum; N: nucleus. [Color figure can be viewed in the online issue,which is available at .]
###end p 49
###begin p 50
###xml 191 204 191 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig04">Fig. 4E and F</xref>
###xml 255 262 255 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig04">Fig. 4G</xref>
###xml 477 484 477 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig04">Fig. 4H</xref>
###xml 433 440 <span type="species:ncbi:9606">patient</span>
On electron micrographs, the inclusions noted at the light microscopy level appeared to be dilated cisternae of rough endoplasmic reticulum that contained flocculent electron dense material (Fig. 4E and F), which were not present in control chondrocytes (Fig. 4G). In addition there were numerous phagolysosomes within the chondrocytes but the Golgi was within normal limits. For comparison a chondrocyte from a pseudoachondroplasia patient with a COMP mutation is also shown (Fig. 4H). In summary therefore the chondrocytes appeared to have a normal morphology but with cytoplasmic inclusions that contained matrilin-3. Overall these in vivo findings confirm the in vitro expression data and suggest that misfolding of the A-domain results in the retention of matrilin-3 within the rER of chondrocytes.
###end p 50
###begin title 51
DISCUSSION
###end title 51
###begin p 52
###xml 279 303 279 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4">Briggs and Chapman, 2002</xref>
###xml 305 326 305 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b35">Unger and Hecht, 2001</xref>
###xml 437 441 437 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMP</italic>
###xml 462 476 462 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL9A1, COL9A2</italic>
###xml 481 487 481 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL9A3</italic>
###xml 519 524 519 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MATN3</italic>
###xml 527 551 527 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4">Briggs and Chapman, 2002</xref>
###xml 553 574 553 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b35">Unger and Hecht, 2001</xref>
###xml 684 697 684 697 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A2/DTDST</italic>
###xml 700 723 700 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1">Ballhausen et al., 2003</xref>
###xml 725 751 725 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b34">Superti-Furga et al., 1999</xref>
###xml 869 873 869 873 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMP</italic>
###xml 875 896 875 896 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b35">Unger and Hecht, 2001</xref>
###xml 902 909 902 909 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A2</italic>
###xml 911 931 911 931 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14">Forlino et al., 2005</xref>
###xml 933 962 933 962 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31">Rossi and Superti-Furga, 2001</xref>
###xml 1051 1056 1051 1056 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MATN3</italic>
###xml 1153 1158 1153 1158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MATN3</italic>
The multiple epiphyseal dysplasias are a relatively common and genetically heterogeneous group of inherited bone diseases and to date disease-causing mutations have been identified in six different genes, the products of which are important for cartilage structure and function [Briggs and Chapman, 2002; Unger and Hecht, 2001]. Autosomal dominant MED can result from mutations in the genes encoding cartilage oligomeric matrix protein (COMP), type IX collagen (COL9A1, COL9A2 and COL9A3) and most recently matrilin-3 (MATN3) [Briggs and Chapman, 2002; Unger and Hecht, 2001]. In addition, an autosomal-recessive form of MED can result from mutations in the sulfate transporter 26A2 (SLC26A2/DTDST) [Ballhausen et al., 2003; Superti-Furga et al., 1999]. Although considerable progress has been made in understanding the disease mechanisms of MED caused by mutations in COMP [Unger and Hecht, 2001] and SLC26A2 [Forlino et al., 2005; Rossi and Superti-Furga, 2001], virtually nothing is known about the disease mechanisms of MED caused by mutations in MATN3. The aim of this study therefore was to determine the molecular cell pathology of MED caused by MATN3 mutations.
###end p 52
###begin p 53
###xml 28 33 28 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MATN3</italic>
###xml 123 143 123 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">Chapman et al., 2001</xref>
###xml 145 165 145 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18">Jackson et al., 2004</xref>
###xml 167 187 167 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22">Mabuchi et al., 2004</xref>
###xml 189 209 189 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b26">Mostert et al., 2003</xref>
###xml 655 659 655 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMP</italic>
###xml 671 689 671 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">Hecht et al., 2005</xref>
All of the MED mutations in MATN3 are missense mutations found in exon 2, which encodes the single A-domain of matrilin-3 [Chapman et al., 2001; Jackson et al., 2004; Mabuchi et al., 2004; Mostert et al., 2003]. To study the effect of these mutations on the secretion of matrilin-3 we cloned and expressed full-length wt, mutant (p.Val194Asp) and polymorphic (p.Glu252Lys) matrilin-3 in mammalian cells. Both the wt and p.Glu252Lys proteins were efficiently secreted, whereas the p.Val194Asp protein was retained in the cell lysate, suggesting that the mutation disrupts the secretion of the abnormal protein. These data are similar to those obtained for COMP mutations [Hecht et al., 2005] and suggest a common disease mechanism for this bone dysplasia family.
###end p 53
###begin p 54
###xml 29 34 29 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MATN3</italic>
###xml 161 181 149 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18">Jackson et al., 2004</xref>
###xml 1083 1088 1068 1073 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MATN3</italic>
Most of the MED mutations in MATN3 affect conserved residues in one of the six beta-strands (betaA-betaF) that together comprise the beta-sheet of the A-domain [Jackson et al., 2004]. This precise grouping of MED mutations in the beta-sheet led to us to hypothesize that they might disrupt the folding of this structurally important domain. To investigate this observation further we expressed individual A-domains; either wt or containing a disease-causing mutation (p.Thr120Met, p.Arg121Trp, p.Glu134Lys, p.Ile192Asn, p.Val194Asp and p.Ala219Asp) or non-synonymous polymorphism (p.Glu252Lys). Normal A-domain was expressed and secreted from mammalian cells as a disulfide bonded monomer, demonstrating that this domain can fold independently of the other matrilin-3 modules (i.e., EGF-like motifs and coiled-coil domain). However, in all cells expressing a mutation the recombinant A-domain was retained within the cell lysate and no protein was detected in the cell culture media. These data are therefore in agreement with those obtained for full-length protein and confirm that MATN3 mutations disrupt the secretion of abnormal matrilin-3 by causing misfolding of the A-domain.
###end p 54
###begin p 55
Interestingly, SDS-PAGE of cell lysates under nonreducing conditions identified both a disulfide bonded ("folded") A-domain and a non-disulfide bonded ("unfolded") intermediate. This measurable characteristic of the expressed A-domains provided us with the means to study further the effect of the specific disease-causing mutations on the folding of single A-domains. Analysis of the retained mutant A-domains demonstrated that they existed primarily as non-disulfide bonded folding intermediates (approximately 9/1: nondisulfide/disulfide bonded). In addition disulfide bonded dimers and trimers were also detected, suggesting a potential mechanism for the aggregation of misfolded matrilin-3 within the rER.
###end p 55
###begin p 56
###xml 605 625 593 613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22">Mabuchi et al., 2004</xref>
In contrast, recombinant A-domain containing p.Glu252Lys, a non-disease-causing polymorphism, was secreted in a similar manner to normal A-domain and also had a similar proportion of non-disulfide bonded protein in the cell lysate. This polymorphism results in an amino acid substitution in one of the external alpha-helices of the A-domain (alpha-7) and we hypothesize that such a substitution is unlikely to prevent the correct folding of the A-domain. Interestingly a recent study has reported a MED-causing mutation (p.Phe105Ser) in the alpha1 helix of the matrilin-3 A-domain in one Japanese family [Mabuchi et al., 2004]. This mutation affects a highly conserved phenylalanine residue, which unlike Glu252 may be important for the structure and/or function of matrilin-3. Structural and functional analysis of p.Phe105Ser will help elucidate the role of this mutation in the pathogenesis of MED.
###end p 56
###begin p 57
###xml 180 202 180 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b21">Kuznetsov et al., 1997</xref>
###xml 339 366 339 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b7">Clissold and Bicknell, 2003</xref>
###xml 368 392 368 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12">Ferrari and Soling, 1999</xref>
###xml 714 737 714 737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24">Mazzarella et al., 1990</xref>
###xml 1027 1045 1027 1045 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">Hecht et al., 2001</xref>
###xml 960 968 <span type="species:ncbi:9606">patients</span>
Since mutant A-domains were persisting as non-disulfide bonded ("unfolded") intermediates we decided to examine the role that specific chaperone proteins may play in this process [Kuznetsov et al., 1997]. In particular we were interested in chaperone proteins that are specifically involved in catalyzing the formation of disulfide bonds [Clissold and Bicknell, 2003; Ferrari and Soling, 1999]. Analysis by coimmunoprecipitation revealed that only mutant A-domain formed a stable complex with ERp72. ERp72 is an abundant endoplasmic reticulum protein that contains three copies of the active site sequences of protein disulfide isomerase and plays an important role in catalyzing the formation of disulfide bonds [Mazzarella et al., 1990]. In addition it has also been shown to play a key role in the unfolded protein response (UPR) and has in fact been implicated in the retention of misfolded COMP in the chondrocytes of pseudoachondroplasia (PSACH) and MED patients resulting from mutations in the type III repeats of COMP [Hecht et al., 2001]. Our data therefore suggest that mutant A-domains experience a disruption in folding, which hinders the formation of intrachain disulfide bonds but still allows the formation of inappropriate interchain disulfide bonds between other A-domains thus producing both dimers and trimers. However we were not able to determine whether binding of ERp72 to mutant A-domain is a cause or a consequence of the delayed folding.
###end p 57
###begin p 58
###xml 81 89 81 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 148 153 148 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MATN3</italic>
###xml 533 538 533 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MATN3</italic>
###xml 133 140 <span type="species:ncbi:9606">patient</span>
###xml 684 691 <span type="species:ncbi:9606">patient</span>
Although our initial studies were focused on understanding the disease mechanism in vitro, the chance to study cartilage from an MED patient with a MATN3 mutation (p.Arg121Trp) provided us with the opportunity to confirm these findings in vivo. Analysis by light and electron microscopy revealed the retention of protein within the rER of chondrocytes. Furthermore immunohistochemistry revealed that the retained protein stained with antibodies against matrilin-3. These data therefore confirm our in vitro findings and suggest that MATN3 mutations result in the misfolding of the matrilin-3 A-domain, which subsequently results in the retention of matrilin-3 oligomers in the rER of patient chondrocytes.
###end p 58
###begin p 59
###xml 57 62 57 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MATN3</italic>
###xml 275 296 275 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b35">Unger and Hecht, 2001</xref>
###xml 415 417 415 417 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 434 458 434 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b20">Kleerekoper et al., 2002</xref>
###xml 568 587 568 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b10">Dinser et al., 2002</xref>
###xml 779 798 779 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b36">Vranka et al., 2001</xref>
###xml 816 835 816 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">Hecht et al. [2005]</xref>
###xml 1083 1100 1083 1100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b11">Duke et al., 2003</xref>
###xml 1212 1230 1212 1230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">Hecht et al., 2001</xref>
###xml 1232 1251 1232 1251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b36">Vranka et al., 2001</xref>
Therefore, the molecular cell pathology of MED caused by MATN3 mutations has similarities to skeletal dysplasias caused by mutations in the genes encoding other extracellular matrix structural proteins, particularly PSACH and forms of MED that result from mutations in COMP [Unger and Hecht, 2001]. In these allelic diseases, mutations in the type III repeats of COMP result in the persistence of an unstructured Ca2+ binding domain [Kleerekoper et al., 2002]. These abnormal COMP molecules are then retained within the rER of cells via the unfolded protein response [Dinser et al., 2002]. The primary accumulation of abnormal COMP also appears to result in the secondary retention of type IX collagen and other proteins, eventually producing large insoluble "inclusion bodies" [Vranka et al., 2001]. More recently, Hecht et al. [2005] showed that mutant COMP can also dramatically affect the secretion of normal matrilin-3 from PSACH chondrocytes. This mass accumulation of protein eventually results in cell death and a reduction in the number of viable cells in the growth plate [Duke et al., 2003]. Interestingly a number of chaperone proteins have been shown to be involved in this process including ERp72 [Hecht et al., 2001; Vranka et al., 2001].
###end p 59
###begin p 60
###xml 215 239 215 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4">Briggs and Chapman, 2002</xref>
###xml 241 262 241 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b35">Unger and Hecht, 2001</xref>
###xml 526 550 526 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4">Briggs and Chapman, 2002</xref>
###xml 682 703 682 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b35">Unger and Hecht, 2001</xref>
###xml 746 765 746 765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b10">Dinser et al., 2002</xref>
###xml 983 988 983 988 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MATN3</italic>
MED is perhaps the most genetically heterogeneous of all autosomal dominant skeletal dysplasia phenotypes and missense mutations have now been identified in the genes encoding matrilin-3, COMP and type IX collagen [Briggs and Chapman, 2002; Unger and Hecht, 2001]. Recently there has been much speculation about the reason for this genetic heterogeneity, and a number of hypotheses have been suggested; i.e., 1) some mutations disrupt specific interactions between matrilin-3, type IX collagen, and COMP in the cartilage ECM [Briggs and Chapman, 2002]; 2) the blocked/delayed secretion of one mutant protein results in a cascade of protein retention within the rER of chondrocytes [Unger and Hecht, 2001]; or 3) a combination of both mechanisms [Dinser et al., 2002]. In summary, our data suggest that the retention of mutant cartilage structural protein, within the rough endoplasmic reticulum, is a common disease mechanism that is shared between MED resulting from either COMP or MATN3 mutations.
###end p 60
###begin p 61
This work was supported in part by grants from the Wellcome Trust (060801 to M.D.B.), the European Commission (Grant QLG1-CT-2001-02188 to M.D.B. and others to support the European Skeletal Dysplasia Network; ), and the Deutsch Forschungsgemeinschaft (Wa 1338/2-2 to R.W.) M.D.B. is the recipient of a Wellcome Trust Senior Research Fellowship in Basic Biomedical Sciences (071161). A full-length matrilin-3 cDNA clone was the kind gift of Dr. Debbie Krakow (Cedars Sinai Medical Center, Los Angeles, CA).
###end p 61
###begin title 62
REFERENCES
###end title 62
###begin article-title 63
Recessive multiple epiphyseal dysplasia (rMED): phenotype delineation in eighteen homozygotes for DTDST mutation R279W
###end article-title 63
###begin article-title 64
###xml 38 43 38 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MATN3</italic>
###xml 20 25 <span type="species:ncbi:9606">human</span>
Characterization of human matrilin-3 (MATN3)
###end article-title 64
###begin article-title 65
Spondylo-epi-metaphyseal dysplasia (SEMD) matrilin 3 type: homozygote matrilin 3 mutation in a novel form of SEMD
###end article-title 65
###begin article-title 66
Pseudoachondroplasia and multiple epiphyseal dysplasia: mutation review, molecular interactions, and genotype to phenotype correlations
###end article-title 66
###begin article-title 67
Pseudoachondroplasia and multiple epiphyseal dysplasia due to mutations in the cartilage oligomeric matrix protein gene
###end article-title 67
###begin article-title 68
Mutations in the region encoding the von Willebrand factor A domain of matrilin-3 are associated with multiple epiphyseal dysplasia
###end article-title 68
###begin article-title 69
The thioredoxin-like fold: hidden domains in protein disulfide isomerases and other chaperone proteins
###end article-title 69
###begin article-title 70
A mutation in COL9A1 causes multiple epiphyseal dysplasia: further evidence for locus heterogeneity
###end article-title 70
###begin article-title 71
Ligand recognition by the I domain-containing integrins
###end article-title 71
###begin article-title 72
Pseudoachondroplasia is caused through both intra- and extracellular pathogenic pathways
###end article-title 72
###begin article-title 73
Apoptosis staining in cultured pseudoachondroplasia chondrocytes
###end article-title 73
###begin article-title 74
The protein disulphide-isomerase family: unravelling a string of folds
###end article-title 74
###begin article-title 75
WARP is a new member of the von Willebrand factor A-domain superfamily of extracellular matrix proteins
###end article-title 75
###begin article-title 76
###xml 61 66 <span type="species:ncbi:10090">mouse</span>
A diastrophic dysplasia sulfate transporter (SLC26A2) mutant mouse: morphological and biochemical characterization of the resulting chondrodysplasia phenotype
###end article-title 76
###begin article-title 77
COMP mutations, chondrocyte function and cartilage matrix
###end article-title 77
###begin article-title 78
Calreticulin, PDI, Grp94 and BiP chaperone proteins are associated with retained COMP in pseudoachondroplasia chondrocytes
###end article-title 78
###begin article-title 79
Domain structure and organisation in extracellular matrix proteins
###end article-title 79
###begin article-title 80
Mutations in the beta-sheet regions of the matrilin-3 A-domain result in phenotypes within the multiple epiphyseal dysplasia disease spectrum
###end article-title 80
###begin article-title 81
Molecular structure and tissue distribution of matrilin-3, a filament-forming extracellular matrix protein expressed during skeletal development
###end article-title 81
###begin article-title 82
Disease-causing mutations in cartilage oligomeric matrix protein cause an unstructured Ca2+ binding domain
###end article-title 82
###begin article-title 83
Multiple molecular chaperones complex with misfolded large oligomeric glycoproteins in the endoplasmic reticulum
###end article-title 83
###begin article-title 84
###xml 81 86 81 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MATN3</italic>
Novel and recurrent mutations clustered in the von Willebrand factor A domain of MATN3 in multiple epiphyseal dysplasia
###end article-title 84
###begin article-title 85
Interactions between the cartilage oligomeric matrix protein and matrilins. Implications for matrix assembly and the pathogenesis of chondrodysplasias
###end article-title 85
###begin article-title 86
ERp72, an abundant luminal endoplasmic reticulum protein, contains three copies of the active site sequences of protein disulfide isomerase
###end article-title 86
###begin article-title 87
Morphology and chemical composition of connective tissue: cartilage
###end article-title 87
###begin article-title 88
Familial multiple epiphyseal dysplasia due to a matrilin-3 mutation: further delineation of the phenotype including 40 years follow-up
###end article-title 88
###begin article-title 89
A mutation in the gene encoding the alpha 2 chain of the fibril-associated collagen IX, COL9A2, causes multiple epiphyseal dysplasia (EDM2)
###end article-title 89
###begin article-title 90
COL9A3: a third locus for multiple epiphyseal dysplasia
###end article-title 90
###begin article-title 91
Missense mutation in a von Willebrand factor type A domain of the alpha 3(VI) collagen gene (COL6A3) in a family with Bethlem myopathy
###end article-title 91
###begin article-title 92
###xml 86 94 <span type="species:ncbi:9606">patients</span>
Ser968Thr mutation within the A3 domain of von Willebrand factor (VWF) in two related patients leads to a defective binding of VWF to collagen
###end article-title 92
###begin article-title 93
Mutations in the diastrophic dysplasia sulfate transporter (DTDST) gene (SLC26A2): 22 novel mutations, mutation review, associated skeletal phenotypes, and diagnostic relevance
###end article-title 93
###begin article-title 94
A Bethlem myopathy Gly to Glu mutation in the von Willebrand factor A domain N2 of the collagen alpha3(VI) chain interferes with protein folding
###end article-title 94
###begin article-title 95
Genomewide scan for hand osteoarthritis: a novel mutation in matrilin-3
###end article-title 95
###begin article-title 96
Recessively inherited multiple epiphyseal dysplasia with normal stature, club foot, and double layered patella caused by a DTDST mutation
###end article-title 96
###begin article-title 97
Pseudoachondroplasia and multiple epiphyseal dysplasia: New etiologic developments
###end article-title 97
###begin article-title 98
Selective intracellular retention of extracellular matrix proteins and chaperones associated with pseudoachondroplasia
###end article-title 98
###begin article-title 99
Primary structure of matrilin-3, a new member of a family of extracellular matrix proteins related to cartilage matrix protein (matrilin-1) and von Willebrand factor
###end article-title 99
###begin article-title 100
The matrilins-adaptor proteins in the extracellular matrix
###end article-title 100
###begin article-title 101
Distribution and evolution of Von Willebrand/integrin a domains: widely dispersed domains with roles in cell adhesion and elsewhere
###end article-title 101
###begin article-title 102
###xml 63 69 <span type="species:ncbi:9913">bovine</span>
Matrilin-3 forms disulfide-linked oligomers with matrilin-1 in bovine epiphyseal cartilage
###end article-title 102

